CCL4L polymorphisms and CCL4/CCL4L serum levels are associated with psoriasis severity.
暂无分享,去创建一个
M. Juan | R. Faner | R. Colobran | R. Pujol-Borrell | I. Pujol-Autonell | A. Boada | J. Carrascosa | C. Ferrándiz | A. Esteve | E. Palou | L. Carretero-Iglesia | E. Pedrosa
[1] M. Juan,et al. Copy number variation in chemokine superfamily: the complex scene of CCL3L–CCL4L genes in health and disease , 2010, Clinical and experimental immunology.
[2] K. Yan,et al. Foxp3+ regulatory T cells and related cytokines differentially expressed in plaque vs. guttate psoriasis vulgaris , 2010, The British journal of dermatology.
[3] Andrew Johnston,et al. Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. , 2010, The Journal of investigative dermatology.
[4] A. Blauvelt,et al. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. , 2010, The Journal of investigative dermatology.
[5] Andrew Johnston,et al. Molecular dissection of psoriasis: integrating genetics and biology. , 2010, The Journal of investigative dermatology.
[6] Juan Cheng,et al. Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. , 2010, Clinical immunology.
[7] X. Estivill,et al. Replication of LCE3C-LCE3B CNV as a risk factor for psoriasis and analysis of interaction with other genetic risk factors. , 2010, Journal of Investigative Dermatology.
[8] J. Lupski,et al. Genomic disorders: A window into human gene and genome evolution , 2010, Proceedings of the National Academy of Sciences.
[9] A. Enk,et al. Chemokine receptors in T-cell-mediated diseases of the skin. , 2009, The Journal of investigative dermatology.
[10] Frank O. Nestle,et al. Mechanisms of Disease: Psoriasis. , 2009 .
[11] J. M. Carrascosa,et al. Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis moderada a grave con agentes biológicos , 2009 .
[12] T. Vyse,et al. Copy number variation in the human genome and its implication in autoimmunity , 2009, Clinical and experimental immunology.
[13] M. Juan,et al. Copy number variation in the CCL4L gene is associated with susceptibility to acute rejection in lung transplantation , 2009, Genes and Immunity.
[14] S. Mummidi,et al. Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children , 2009, AIDS.
[15] James T. Elder,et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis , 2009, Nature Genetics.
[16] Pui-Yan Kwok,et al. Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways , 2008, Nature Genetics.
[17] Kenneth G. C. Smith,et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake , 2008, The Journal of experimental medicine.
[18] Mark I. McCarthy,et al. A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs) , 2008, PLoS genetics.
[19] Lisa C. Zaba,et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. , 2008, The Journal of investigative dermatology.
[20] D. Comas,et al. Population structure in copy number variation and SNPs in the CCL4L chemokine gene , 2008, Genes and Immunity.
[21] Hong Xin,et al. The cytokine and chemokine network in psoriasis. , 2007, Clinics in dermatology.
[22] James G. Krueger,et al. Pathogenesis and therapy of psoriasis , 2007, Nature.
[23] Lawrence Steinman,et al. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.
[24] Steven J. Schrodi,et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. , 2007, American journal of human genetics.
[25] D. Conrad,et al. Global variation in copy number in the human genome , 2006, Nature.
[26] B. Mulloy,et al. Cytokines and proteoglycans: an introductory overview. , 2006, Biochemical Society transactions.
[27] Stefan Jenisch,et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. , 2006, American journal of human genetics.
[28] M. Juan,et al. Multiple Products Derived from Two CCL4 Loci: High Incidence of a New Polymorphism in HIV+ Patients1 , 2005, The Journal of Immunology.
[29] A. Bowcock,et al. Psoriasis pathophysiology: current concepts of pathogenesis , 2005, Annals of the rheumatic diseases.
[30] E. von Stebut,et al. Macrophage inflammatory protein-1. , 2004, The international journal of biochemistry & cell biology.
[31] W. Modi,et al. Functional redundancy of the human CCL4 and CCL4L1 chemokine genes. , 2004, Biochemical and biophysical research communications.
[32] G. Girolomoni,et al. Chemokine networks in inflammatory skin diseases. , 2004, European journal of dermatology : EJD.
[33] J. Travers,et al. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. , 2003, The Journal of allergy and clinical immunology.
[34] J. Van Damme,et al. Macrophage inflammatory protein-1. , 2002, Cytokine & growth factor reviews.
[35] L. Barcellos,et al. Gene copy number regulates the production of the human chemokine CCL3‐L1 , 2002, European journal of immunology.
[36] Klaus Ley,et al. Chemokines and chemokine receptors in leukocyte trafficking. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.
[37] J. A. Smandía,et al. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. , 2002, Journal of the American Academy of Dermatology.
[38] J. Bergeron,et al. The human MIP-1β chemokine is encoded by two paralogous genes, ACT-2 and LAG-1 , 2001, Immunogenetics.
[39] J. Cyster,et al. Chemokines as regulators of T cell differentiation , 2001, Nature Immunology.
[40] T. Ruzicka,et al. Psoriasis: the plot thickens . . . , 2001, Nature Immunology.
[41] A. Gottlieb,et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells , 1995, The Journal of experimental medicine.
[42] J. Carrascosa,et al. [Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents]. , 2009, Actas dermo-sifiliograficas.
[43] André Reis,et al. Psoriasis is associated with increased β-defensin genomic copy number , 2008, Nature Genetics.